News and Trends 1 Nov 2016
Novo Nordisk pressured into Dropping Needle-Free Oral Insulin
Needle-free diabetes will have to wait: payers are pressuring pharma to provide lower medication prices, and Novo Nordisk has responded by redirecting its R&D strategy into more innovative research. Despite…